首页 正文

The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus

{{output}}
Patients with Type 2 diabetes mellitus (T2DM) are at high risk of developing cardiovascular disease (CVD). Treatment of diabetic dyslipidemia, comprised mainly of hypertriglyceridemia, and low HDL-C, with either statin or fibrate monotherapy, is moderately eff... ...